All In Biotech

Free tool

FAERS Monitor: Herzuma

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761091 or its brand name (Herzuma, Trastuzumab-Pkrb). Reports on generic versions are filed under their own applications.

Reports

32,423

Serious

30,766

95% of reports

Hospitalization

12,261

Death reported

3,648

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea3,657
  • off label use3,026
  • nausea2,557
  • fatigue2,208
  • myelosuppression1,886
  • vomiting1,727
  • disease progression1,701
  • neutropenia1,626
  • dyspnoea1,387
  • pyrexia1,340
  • anaemia1,289
  • neuropathy peripheral1,236
  • alopecia1,216
  • asthenia1,205
  • ejection fraction decreased1,159

Reports by year received

View as table
YearReports
200425
200539
200613
200780
2008152
2009312
2010444
2011393
2012699
2013841
2014712
2015856
2016810
2017883
20181,720
20192,307
20202,688
20213,185
20223,200
20233,177
20244,135
20253,350
20262,402

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,736 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ejection fraction decreasedSignal1,15952.249.253,833
myelosuppressionSignal1,88635.834.260,511
disease progressionSignal1,7019.49.012,726
neuropathy peripheralSignal1,2368.58.18,135
neutropeniaSignal1,6267.87.59,642
anaemiaSignal1,2894.44.23,400
alopeciaSignal1,2164.03.82,782
diarrhoeaSignal3,6573.73.67,355
pyrexiaSignal1,3402.52.41,241
vomitingSignal1,7272.42.31,418
off label useSignal3,0262.22.22,174
nauseaSignal2,5572.12.01,524
astheniaSignal1,2052.12.0687
fatigue2,2081.81.8879
dyspnoea1,3871.61.5311

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.